ArticleTranslational andrology and urology2019

Enhancing response to immunotherapy in urothelial carcinoma by targeted inhibition of the histone methyltransferase G9a pathway.

Denzel Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.